Navigation Links
Flexi-Seal(R) Fecal Management System Receives 2008 Critical Care Nurse Advertising Effectiveness Award
Date:7/17/2009

SKILLMAN, N.J., July 17 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it received first place (Total Recall Category) in the 2008 Critical Care Nurse Advertising Effectiveness Awards for its Flexi-Seal((R) )Fecal Management System (FMS).

The innovative Flexi-Seal((R)) FMS, a temporary containment device for patients with acute fecal incontinence, was designed to safely and effectively divert liquid or semi-liquid fecal matter, help protect patients' wounds from fecal contamination, and reduce the risk of both skin breakdown and spread of infection, such as infection with Clostridium difficile (C. difficile).

"ConvaTec is proud to receive this recognition for Flexi-Seal((R) )FMS from our important customers in critical care nursing," said Michael Steadman, President, ConvaTec USA. "As the leader in helping clinicians manage acute fecal incontinence, we are continuing to respond to customer and patient needs with upgraded and improved features -- an approach that has made Flexi-Seal((R) )FMS the number one brand in the U.S. today."(1) ( )

Critical Care Nurse presented the Award to ConvaTec based on reader responses to a survey comparing 17 advertisements in the publication's October 2008 issue. Survey respondents ranked the Flexi-Seal((R)) FMS advertisement best in the Total Recall Category, with 90 percent responding that they recalled seeing the advertisement, and rated it highly for visual appeal, ease of reading and showing the benefits of the product.

Flexi-Seal((R)) FMS is widely used at over 1,800 intensive care unit hospitals(2) in the United States, and more than 500,000 patients have benefited from the use of Flexi-Seal((R)) FMS.(2) ConvaTec continues to support healthcare professionals with a dedicated on-call nurse specialist program. To date, more than 110,000 nurses have been trained on Flexi-Seal((R)) FMS.(3)( )

In October 2008, ConvaTec also introduced Flexi-Seal((R)) FMS Advanced Odor Control, specifically designed to help manage odor* associated with fecal incontinence. While maintaining all of the benefits of the original product, Flexi-Seal((R) )FMS Advanced Odor Control has been shown to successfully eliminate* catheter odor permeation to levels below those that are humanly detectable. Parylene-coated silicone catheters do not effectively manage odor.(4)

* Eliminates perceptible naphthalenic (indole) and sulfide odors radiating from the catheter tube.

In response to the increased focus on pressure ulcer prevention, especially following the inclusion of Stage 3 and 4 pressure ulcers acquired after admission to a healthcare facility on the list of "never events" by the Centers for Medicare and Medicaid Services (CMS), ConvaTec is also conducting a clinical road show focusing on helping to prevent hospital-acquired pressure ulcers, as well as helping to reduce the risk of spread of infection, throughout 2009.

About Flexi-Seal((R)) FMS

Flexi-Seal((R)) FMS is a temporary containment device indicated for patients with liquid to semi-liquid fecal matter and little or no bowel control, and can be used for up to 29 consecutive days. Unique features of Flexi-Seal((R)) FMS include:

  • A soft, low-pressure balloon designed to aid easy insertion and removal and minimize the chance of tissue necrosis.
  • A closed-end collection bag, designed to help reduce the spread of infection.
  • A unique, patented finger pocket guides easy insertion.
  • An entirely latex-free design.

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions -- Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices -- ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit www.convatec.com.

1. HPIS. Moving Annual Total (MAT) Fecal Control Category. Q1 2009. Data on file, ConvaTec.

2. Cognos. Redistributed YTD Sales through April 2009. Data on file, ConvaTec.

3. Inventiv. Monthly In-Service Report through May 2009. Data on file, ConvaTec.

4. Odor Reduction in Fecal Management Devices. White Paper. February 24, 2009. Data on file, ConvaTec.

Flexi-Seal is a registered trademark of ConvaTec Inc.

Our world is what we make of it is a trademark of ConvaTec Inc.

(C) 2009 ConvaTec Inc. AP-007856-US

    Contacts
    Punnie Donohue                           Courtney Judd
    ConvaTec                                 Weber Shandwick
    908-904-2151                             212-445-8365
    punnie.donohue@convatec.com              cjudd@webershandwick.com


'/>"/>
SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New B-SURE Pads Are The Ideal Alternative Product To Use For Mild Fecal Incontinence - Small, Discrete, Absorbent - Order Online At www.birchwoodmedical.com
2. Simple, inexpensive and objective tools for the assessment of mucosal inflammation: fecal markers
3. NIH panel seeks to dispel stigma associated with fecal and urinary incontinence
4. Fecal Blood Tests Effective at Spotting Colon Cancer
5. School of Health Management Honors 162 Graduating Students
6. Radiology Benefit Management Could Save Medicare up to $18 Billion Over 10 Years
7. URAC Seeks Public Input on New Uniform External Review Standards for Health Plan and Health Utilization Management Organizations
8. Critical Access Hospital Consolidator Seeks Cost-Management Solutions with Broadlane
9. Digital Storage Solutions Changes Name to Shoreline Records Management, Inc.
10. HealthFitness Makes Compelling Case for Employee Health Management
11. OneTouch(R) Ping(TM) Glucose Management System Approved by Health Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: